Therapy-related, donor-derived AML responding to a second allogeneic BMT.
Jacobs
J F M
JF
Brons
P P
PP
Simons
A
A
van der Reijden
B A
BA
Hoogerbrugge
P M
PM
D000208:Acute Disease; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D020732:Cytogenetic Analysis; D015321:Gene Rearrangement; D006801:Humans; D007223:Infant; D007951:Leukemia, Myeloid / Q000209:etiology* / Q000235:genetics / Q000628:therapy*; D008297:Male; D016609:Neoplasms, Second Primary / Q000235:genetics / Q000628:therapy*; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D014019:Tissue Donors; D014184:Transplantation, Homologous